GNOMGlobal X Funds - Global X Genomics & Biotechnology ETF
$57.01
$0.2283
(0.41%)
Today
·Closed $55.99
$1.02
(1.82%)
After Hours
Vol22,460.00
52W High$59.48
52W Low$34.04
News
all
press releases
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead?
Biotech ETFs are surging in 2026 as a friendlier FDA, strong M&A activity and AI-driven drug discovery fuel optimism for more upside.
Zacks
More News
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM
IBB and peers are gaining traction as AI transforms biotech, boosting drug discovery, trials and growth prospects across diversified ETF portfolios.
Zacks
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave
IBB and other biotech ETFs are gaining traction as AI reshapes drug discovery, genomics, and clinical trials, giving investors diversified exposure to biotech innovation.
Zacks
Why Is CRSP Stock Falling Pre-Market Today?
The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.
Stocktwits
Why Did BNTX Stock Tumble 17% Pre-Market Today?
BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.
Stocktwits
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review
The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.